In PROGRESS Cohort 2, zilurgisertib reduced total HO volume vs placebo at 24 weeks in children aged 6 to 11 with FOP, with no new HO lesions.

FDA approves berotralstat 150-mg oral pellets for HAE prophylaxis in patients 12+ who cannot or prefer not to swallow capsules.

Johns Hopkins Children's Center experts outline pedestrian, burn, allergy, anxiety, and candy guidance pediatricians can share before Halloween.

Pumpkin carving accounts for 55% of Halloween ED injuries; AAOS outlines prevention tips for carving, costumes, and trick-or-treating.

NHIS data show the share of US children aged 5 to 17 years ever diagnosed with ADHD climbed from 9.9% in 2019 to 13.8% in 2025.

A proposed rule would revise iodine, manganese, and vitamin A and D levels in infant formula and reaffirm 4 other nutrient specifications.

A review of 93 studies links pediatric home-based hospice and palliative care to fewer hospital days, lower costs, and better family QOL.

With California WNV activity at a 5-year high, CHLA outlines age-based repellent and bite-prevention guidance for children.